MBS/Vox hires two new analysts

MBS/Vox, the research-based consultancy unit of CommonHealth specializing in the linguistic analysis of healthcare communication, today announced two new hires. CommonHealth (www.commonhealth.com) is the world's leading healthcare-communications network and a WPP (NASDAQ: WPPGY) (www.wpp.com) company.

New Hires

David Curry, with an MBA in pharmaceutical business from the University of the Sciences in Philadelphia, PA, joins MBS/Vox as a senior analyst. In his role at MBS/Vox, Mr. Curry will be analyzing data from naturally occurring healthcare interactions using linguistic techniques. He'll be applying qualitative and quantitative metrics, and working across a variety of disease states. Prior to joining MBS/Vox, Mr. Curry was employed in the marketing department of IMS Health, a global healthcare company, in Plymouth Meeting, PA.

Julie Hoops enters MBS/Vox as an analyst. As such, she will be responsible for analyzing healthcare professional-patient interactions that occur within the office setting, and performing ethnographic research in various disease states. Ms. Hoops, having received her master's degree in anthropology from Florida Atlantic University with a focus on medical anthropology, will be leveraging the skill set she has developed during her studies within the market research industry.

Source:

MBS/Vox, part of CommonHealth

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Research suggests no need for yellow fever vaccine booster after initial dose